“…We read the article ‘Durable complete remission with local therapies after neoadjuvant and adjuvant nivolumab in recurrent/metastatic head and neck cancer’ with great interest [1]. Undoubtedly, platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) is one of today’s hot topics with its limited response to immunotherapy and high mortality rates.…”